in type 2 diabetes (T2D), and Real-world research on patients with worsening HF within a large healthcare delivery system from 2012-2021. Details on abstracts presented by Bayer at ACC.25 are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback